-
-
-
-
-
-
-
Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021
-
-
-
-
-
-
-
Meredith To Report Fiscal 2022 First Quarter Results
-
-
-
-
-
-
-
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
-
-
-
-
-
-
-
Meredith To Report Fiscal 2021 Third Quarter Results April 29
-
-
-
-
-
-
-
Wyndham Destinations Acquires Travel + Leisure Brand from Meredith Corporation in Strategic Alliance; Wyndham Destinations to Be Renamed Travel + Leisure Co.
-
-
-
-
-
-
-
Medexus Pharmaceuticals Reports Record Revenue of $27.5 Million and $5.0 Million of Adjusted EBITDA* for the First Quarter of Fiscal 2021
-
-
-
-
-
-
-
Meredith Corp. (MDP) Misses Q3 EPS by 61c, Revenues Miss
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

